Skip to Content
Merck
  • Cerebellar neurodegeneration in a new rat model of episodic hepatic encephalopathy.

Cerebellar neurodegeneration in a new rat model of episodic hepatic encephalopathy.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (2016-05-08)
Teresa García-Lezana, Marc Oria, Jordi Romero-Giménez, Jordi Bové, Miquel Vila, Joan Genescà, Laia Chavarria, Juan Cordoba
ABSTRACT

Hepatic encephalopathy has traditionally been considered a reversible disorder. However, recent studies suggested that repeated episodes of hepatic encephalopathy cause persistent impairment leading to neuronal loss. The aims of our study were the development of a new animal model that reproduces the course of episodic hepatic encephalopathy and the identification of neurodegeneration evidences. Rats with portacaval anastomosis underwent simulated episodes of hepatic encephalopathy, triggered by the regular administration of ammonium acetate, and/or lipopolysaccharide. The neurological status was assessed and neuronal loss stereologically quantified in motor areas. During the simulated episodes, ammonia induced reversible motor impairment in portacaval anastomosis rats. In cerebellum, stereology showed a reduction in Purkinje cell population in portacaval anastomosis and PCA+NH

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Lipopolysaccharides from Klebsiella pneumoniae, purified by phenol extraction